Keys to successful cardiac resynchronization therapy

American Heart Journal

Volumn 153, Issue 4 SUPPL., 2007, Pages 18-24

  Herre, John ^a  

^a Cardiology Consultants Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; IMPLANTATION; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT INDICATION;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE CARE; REMISSION INDUCTION;

EID: 33947529874     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.018     Document Type: Article

References (19)

1. St. John Sutton M.G., Plappert T., Abraham W.T., et al. Effect of cardiac resynchronization on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
2. Abraham W.T., Young J.B., León A.R., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868
3. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
4. Cleland J.G.F., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
5. Hunt S.A., Abraham W.T., Chin M.J., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Available at:. http://%20www.acc.org/clinical/guidelines/failure//index.pdf
6. Leclercq C., Walker S., Linde C., et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 23 (2002) 1780-1787
7. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2059
8. McMurray J., and Pfeffer M.A. New therapeutic options in congestive heart failure: Part I. Circulation 105 (2002) 2099-2106
9. Packer M., Poole-Wilson P.A., Armstrong P.W., et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. The ATLAS Study Group. Circulation 100 (1999) 2312-2318
10. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94 (1996) 2807-2816
11. Aranda Jr. J.M., Woo G.W., Schofield R.S., et al. Management of heart failure after cardiac resynchronization therapy. Integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol 46 (2005) 2193-2198
12. Adamson P.B., and Abraham W.T. Cardiac resynchronization therapy for advanced heart failure. Curr Treat Options Cardiovasc Med 5 (2003) 301-309
13. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 24 (2005) 945-982
14. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
15. Deng M.C., Edwards L.B., Hertz M.I., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
16. Long J.W., Kfoury A.G., Slaughter M.S., et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 11 (2005) 133-138
17. Felker G.M., and O'Connor C.M. Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 142 (2001) 393-401
18. Sackner-Bernstein J.D., Kowalski M., Fox M., et al. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. JAMA 293 (2005) 1900-1905
19. Mills R.M., LeJemtel T.H., Horton D.P., et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure; a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 34 (1999) 155-162